期刊文献+

来氟米特对大鼠被动型Heymann肾炎的治疗作用 被引量:6

Effect of leflunomide on nephrin mRNA expression in rat with passive Heymann nephritis
下载PDF
导出
摘要 目的:研究来氟米特对被动性Heymann肾炎(PHN)的治疗作用,为临床膜性肾病的治疗提供依据。方法:Wistar大鼠尾静脉注射抗FX1A血清,建立PHN模型;用BCA法测量24h尿蛋白变化,用光镜、电镜观察肾脏病理改变,并用RT-PCR观察nephrinmRNA表达改变。结果:成功复制了PHN模型来氟米特能减轻PHN大鼠蛋白尿,肾脏病变程度,抑制nephrinmRNA表达减少。结论:来氟米特对PHN有一定的治疗作用,可能是通过提高nephrin表达及减少免疫复合物沉积来实现这一作用。 Objective: To investigate the role of leflunomide in the treatment for PHN, and to provide evidence for membranous nephropathy in clinic. Methods: The rat PHN model was induced by injection of anti-FX1A serum through tail vein. Twenty-four hours urine protein, nephrin mRNA expression and glomerular lesions were detected by BCA, RT-PCR and light and electronic micro-scope, respectively. Results: The rat PHN model was establish-ed successfully. Leflunomide reduced urine protein, glomerular lesions of rat with PHN,and increased nephrin mRNA expression. Conclusion: Leflunomide may play a role in the treatment for PHN, possibly by increasing nephrin mRNA expression and decreasing immune complex deposits.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2006年第8期667-670,F0006,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省医学重点人才工程(135)资助项目(RC2002045) 江苏省科技厅资助项目(BK2003109)
关键词 来氟米特 HEYMANN肾炎 NEPHRIN leflunomide Heymann nephritis/passive nephrin
  • 相关文献

参考文献15

  • 1王迎伟,汤仁仙,董红燕.川芎嗪防治被动型Hermann肾炎的实验研究(英文)[J].Journal of Nanjing Medical University,2003,17(4):166-172. 被引量:1
  • 2Marilyn G.farquhar,Akihiko saito,Dontscho kerjaschki,et al.The Heymann Nephritis Antigenic Complex:Megalin (gp330) and RAP1[J].JASN,1995,6:35-47
  • 3Kerjaschki2 D,Neale TJ.Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (heymann nephritis)[J].JASN,1996,8:2518-2526
  • 4Levy J.New aspects in the management of ANCA-positive vasculitis[J].Nephrol Dial Transplant,2001,16:1314-1317
  • 5Yuko mizushima,Yukio amino,Hiroshi kitagawa,et al.Oral Administration of Leflunomide (HWA486) Results in Prominent Suppression of Immunoglobulin E Formation in a Rat Type 1 Allergy Model[J].JPET,1999,288:849-857
  • 6郑振峰,林珊.来氟米特与甲氨蝶呤治疗类风湿性关节炎的Meta分析[J].医师进修杂志,2005,28(12):12-15. 被引量:25
  • 7Gaby palmer,Danielle burger,Francoise mezin,et al.The active metabolite of leflunomide,A77 1726,increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes[J].Arthritis Res Ther,2004,6:181-189
  • 8崔太根,侯凡凡,倪兆慧,陈香美,张凤山,朱彤莹,赵学智,鲍春德,赵明辉,王国保,钱家麒,蔡广研,李英楠,陆福明,梅长林,邹万忠,王海燕.来氟米特联合糖皮质激素治疗增殖型狼疮性肾炎的多中心对照临床试验研究[J].中华内科杂志,2005,44(9):672-676. 被引量:104
  • 9汤力,曹雪莹,赵威,王顺泽,刘旭利,刘志国,陈香美.来氟米特与霉酚酸酯治疗难治性肾病综合征的对照观察[J].北京医学,2004,26(5):297-299. 被引量:14
  • 10Hiroshi Kawachi,Hiroko Koike,Fujio Shimizu.Molecular structure and function of the slit diaphragm:expression of nephrin in proteinuric states and in developing glomeruli[J].Nephrol Dial Transplant,2002,17:20-22

二级参考文献23

  • 1曾富盛 北京.细胞形态立体计量学[M].北京医科大学:协和医科大学联合出版社,1990.148-60.
  • 2Gulati S, Pokhariyal S, Sharma RK, et al. Pulse cyclophosphamide therapy in frequently relapsing nephritic syndrome. Nephrol Dial Transplant,2001,16: 2013 - 2027.
  • 3Robaire B, Hales BF. Mechanisms of action of cyclophosphamide as a male-mediated developed toxicant. Adv Exp Med Biol,2003,518:169- 180.
  • 4Sakai H,Kurolkawa K, Saito T, et al. Guidelines for the management of refractory nephritic syndrome-form investigations between 1997 and 2001 research projectteam for progressive renal lesions in the Ministry of Health, Labor and Welfare, Japan. Nippon Ji
  • 5Wozel G, feiffer C. Leflunomide-a new drug for pharmacological immunomodnlation. H autarzt. 2002,53 (5) :309 - 315.
  • 6Manna SK, Mukhopadhyay A, Aggarawal BB. Leflunomidesuppresses TNF-induced cellular responses: effect on NF-kappa B,activator protein-1,c-Jun N-terminal protein kinase, and apoptosis. J Immunol.2000,165 (10) :5962 ~ 5969.
  • 7Manna SK, Aggarwal BB. Immunosupressive Leflunomide metabolite (A771726) blocks TNF-dependent nuclear factor-k B activation and gene expression. Immunol. 1999,162:2095 - 2102.
  • 8Xiao F, Chong A, Shen J, et al. Pharmacologically induced regession of chronic transplant rejection. Transplantation 60 ( 10 ). 1995,1065 -1072.
  • 9Herrmann ML, Schleyerbach R. Kirschbaum BJ. Leflunomide an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases. Immunopharmacology. 2000,47(2-3) :273- 289.
  • 10Sakurai H, Hisada Y, Ueno M, et al. Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats. Biochim Biophys Acta. 1996,1316(2) :132 - 138.

共引文献134

同被引文献70

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部